26 December 2018 - Pune 26 June 2019 : Dr Cyrus Poonawalla, Founder and Chairman of Serum Institute of India, was conferred with the prestigious 'Degree of Doctor of Science, honoris causa' by the University of Oxford, U.K. at a glittering ceremony on June 26. The University conferred the honorary degree during a ceremony called 'Encaenia'. Dr. Poonawalla is the only person who has been honoured with this degree after Dr. Edward Jenner, who was honoured in the year 1813 in the field of vaccines. This is yet another feather in the cap of Dr. Cyrus Poonawalla who has been widely acknowledged for his unparalleled and continuous mission of global immunization and his path defining philanthropic initiatives.
Founded in 1966, Serum Institute of India is the top biotech company in the country and is now the world's largest manufacturer of life-saving vaccines by number of doses, thus saving the lives of more than 30 million mostly under-privileged children across the globe, who would have otherwise perished without the availability of affordable vaccines.
Also known as a philanthropist, focusing on public causes and underserved communities, Dr Cyrus Poonawalla earlier this year was felicitated with the first-ever 'Vaccine Hero' Award by GAVI (Global Alliance for Vaccine Initiative). He was also conferred with the honorary degree of 'Doctor of Humane Letters' by the University of Massachusetts, Boston, USA last year for his outstanding contribution in improving the public health for all communities..
SERUM INSTITUTE OF INDIA TO PRODUCE UP TO 100 MILLION COVID-19 VACCINE DOSES FOR INDIA AND LOW-AND MIDDLE-INCOME COUNTRIES AS EARLY AS 2021
50% of our Covid vaccines will be for India, people won't have to buy them, govts will pay: Adar Poonawalla
AstraZeneca vaccine's success in early human trials, Will Begin AstraZeneca Vaccine Trial in India After Applying for Licence Next Week, Says Serum Institute
Serum Institute of India CEO: ‘We plan to make millions of doses of Covid vaccine over three months’:’
New supply agreement between UNICEF and Serum Institute of India makes pneumococcal conjugate vaccine available at US$2.00 per dose, a 43 % reduction from the Gavi price at the start of the Advance Market Commitment
Serum Institute confident of manufacturing Covid vaccine’s 100 million doses if trials establish efficacy
Serum Institute’s Journey To Success | ET NOW Covid-19 vaccine possible by Q2 of 2022: Adar Poonawalla
Adar Poonawalla discusses Serum Institute's progress in the global battle against COVID-19 with Shereen Bhan, CNBC-TV18
Adar Poonawalla talks with Aabha Bakaya about the success story of Serum Institute of India. Tune in to know all about the journey of the company.
Bill Gates confers Indian Council of Medical Research "Lifetime Achievement Medal" on Dr. Cyrus Poonawalla
Dr. Cyrus Poonawalla conferred with 'Lifetime Achievement Award’ by the Asian Business Leadership Forum
Dr. Cyrus Poonawalla conferred with the prestigious honorary degree by the University of Oxford, U.K.